Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer ; day:10 ; month:02 ; year:2022 ; extent:13
Advanced materials ; (10.02.2022) (gesamt 13)

Urheber
Yong, Seok‐Beom
Ramishetti, Srinivas
Goldsmith, Meir
Diesendruck, Yael
Hazan‐Halevy, Inbal
Chatterjee, Sushmita
Somu Naidu, Gonna
Ezra, Assaf
Peer, Dan

DOI
10.1002/adma.202106350
URN
urn:nbn:de:101:1-2022021014170294003085
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Yong, Seok‐Beom
  • Ramishetti, Srinivas
  • Goldsmith, Meir
  • Diesendruck, Yael
  • Hazan‐Halevy, Inbal
  • Chatterjee, Sushmita
  • Somu Naidu, Gonna
  • Ezra, Assaf
  • Peer, Dan

Ähnliche Objekte (12)

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy

Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy

Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy

Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy

Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy

Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future

Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future

Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials

Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials

Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy

Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy

Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors

Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors

Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment

Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer

Bioactive fatty acid analog-derived hybrid nanoparticles confer antibody-independent chemo-immunotherapy against carcinoma

Bioactive fatty acid analog-derived hybrid nanoparticles confer antibody-independent chemo-immunotherapy against carcinoma

Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer

Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer

Verbundene Objekte